These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

458 related articles for article (PubMed ID: 24239247)

  • 1. An 1H-MRS framework predicts the onset of Alzheimer's disease symptoms in PSEN1 mutation carriers.
    Londono AC; Castellanos FX; Arbelaez A; Ruiz A; Aguirre-Acevedo DC; Richardson AM; Easteal S; Lidbury BA; Arcos-Burgos M; Lopera F
    Alzheimers Dement; 2014 Sep; 10(5):552-61. PubMed ID: 24239247
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Using proton magnetic resonance spectroscopy to identify mild cognitive impairment.
    Wang T; Xiao S; Li X; Ding B; Ling H; Chen K; Fang Y
    Int Psychogeriatr; 2012 Jan; 24(1):19-27. PubMed ID: 21676281
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Magnetic resonance spectroscopy as a predictor of conversion of mild cognitive impairment to dementia.
    Targosz-Gajniak MG; Siuda JS; Wicher MM; Banasik TJ; Bujak MA; Augusciak-Duma AM; Opala G
    J Neurol Sci; 2013 Dec; 335(1-2):58-63. PubMed ID: 24035276
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Association of 1H-MR spectroscopy and cerebrospinal fluid biomarkers in Alzheimer's disease: diverging behavior at three different brain regions.
    Bittner DM; Heinze HJ; Kaufmann J
    J Alzheimers Dis; 2013; 36(1):155-63. PubMed ID: 23579327
    [TBL] [Abstract][Full Text] [Related]  

  • 5. (1)H-MRS asymmetry changes in the anterior and posterior cingulate gyrus in patients with mild cognitive impairment and mild Alzheimer's disease.
    Guo Z; Liu X; Hou H; Wei F; Chen X; Shen Y; Chen W
    Compr Psychiatry; 2016 Aug; 69():179-85. PubMed ID: 27423359
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Early Alzheimer's disease neuropathology detected by proton MR spectroscopy.
    Murray ME; Przybelski SA; Lesnick TG; Liesinger AM; Spychalla A; Zhang B; Gunter JL; Parisi JE; Boeve BF; Knopman DS; Petersen RC; Jack CR; Dickson DW; Kantarci K
    J Neurosci; 2014 Dec; 34(49):16247-55. PubMed ID: 25471565
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Magnetic resonance spectroscopy performance for detection of dementia, Alzheimer's disease and mild cognitive impairment in a community-based survey.
    García Santos JM; Gavrila D; Antúnez C; Tormo MJ; Salmerón D; Carles R; Jiménez Veiga J; Parrilla G; Torres del Río S; Fortuna L; Navarro C
    Dement Geriatr Cogn Disord; 2008; 26(1):15-25. PubMed ID: 18566544
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Common 1H-MRS Characteristics in Patients With Alzheimer's Disease and Vascular Dementia Diagnosed With Kidney Essence Deficiency Syndrome: A Preliminary Study.
    Guo Z; Liu X; Cao Y; Hou H; Chen X; Chen Y; Huang F; Chen W
    Altern Ther Health Med; 2017 May; 23(3):12-18. PubMed ID: 28236618
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Proton magnetic resonance spectroscopy in mild cognitive impairment and Alzheimer's disease: a preliminary study.
    Suriyajakryuththana W; Tuntiyatorn L; Teepprasarn N; Sukying C
    J Med Assoc Thai; 2014 Apr; 97(4):407-14. PubMed ID: 24964683
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Cerebral metabolism in patients with cognitive disorders: a combined MRS and PET study].
    Khomenko YG; Kataeva GV; Bogdan AA; Chernysheva EM; Susin DS
    Zh Nevrol Psikhiatr Im S S Korsakova; 2019; 119(1):51-58. PubMed ID: 30778031
    [TBL] [Abstract][Full Text] [Related]  

  • 11. MRS in mild cognitive impairment: early differentiation of dementia with Lewy bodies and Alzheimer's disease.
    Zhang B; Ferman TJ; Boeve BF; Smith GE; Maroney-Smith M; Spychalla AJ; Knopman DS; Jack CR; Petersen RC; Kantarci K
    J Neuroimaging; 2015; 25(2):269-274. PubMed ID: 25039916
    [TBL] [Abstract][Full Text] [Related]  

  • 12. 1H-proton magnetic resonance spectroscopy differentiates dementia with Lewy bodies from Alzheimer's disease.
    Zhong X; Shi H; Shen Z; Hou L; Luo X; Chen X; Liu S; Zhang Y; Zheng D; Tan Y; Huang G; Fang Y; Zhang H; Mu N; Chen J; Wu R; Ning Y
    J Alzheimers Dis; 2014; 40(4):953-66. PubMed ID: 24531156
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Whole-brain patterns of (1)H-magnetic resonance spectroscopy imaging in Alzheimer's disease and dementia with Lewy bodies.
    Su L; Blamire AM; Watson R; He J; Hayes L; O'Brien JT
    Transl Psychiatry; 2016 Aug; 6(8):e877. PubMed ID: 27576166
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Cognitive impairment: classification by proton magnetic resonance spectroscopy and the contributions of conventional magnetic resonance imaging].
    Martínez-Bisbal MC; Arana E; Martí-Bonmatí L; Martínez-Granados B; Celda B
    Radiologia; 2006; 48(5):301-7. PubMed ID: 17168239
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Regional metabolic changes in the hippocampus and posterior cingulate area detected with 3-Tesla magnetic resonance spectroscopy in patients with mild cognitive impairment and Alzheimer disease.
    Wang Z; Zhao C; Yu L; Zhou W; Li K
    Acta Radiol; 2009 Apr; 50(3):312-9. PubMed ID: 19235582
    [TBL] [Abstract][Full Text] [Related]  

  • 16.
    Joe E; Medina LD; Ringman JM; O'Neill J
    Brain Imaging Behav; 2019 Aug; 13(4):925-932. PubMed ID: 29907927
    [No Abstract]   [Full Text] [Related]  

  • 17. Effects of donepezil on brain morphometric and metabolic changes in patients with Alzheimer's disease: A DARTEL-based VBM and (1)H-MRS.
    Moon CM; Kim BC; Jeong GW
    Magn Reson Imaging; 2016 Sep; 34(7):1008-16. PubMed ID: 27131829
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Hippocampal proton MR spectroscopy in early Alzheimer's disease and mild cognitive impairment.
    Foy CM; Daly EM; Glover A; O'Gorman R; Simmons A; Murphy DG; Lovestone S
    Brain Topogr; 2011 Oct; 24(3-4):316-22. PubMed ID: 21298332
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Regional metabolic patterns in mild cognitive impairment and Alzheimer's disease: A 1H MRS study.
    Kantarci K; Jack CR; Xu YC; Campeau NG; O'Brien PC; Smith GE; Ivnik RJ; Boeve BF; Kokmen E; Tangalos EG; Petersen RC
    Neurology; 2000 Jul; 55(2):210-7. PubMed ID: 10908893
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Hippocampal metabolic abnormalities in mild cognitive impairment and Alzheimer's disease.
    Ackl N; Ising M; Schreiber YA; Atiya M; Sonntag A; Auer DP
    Neurosci Lett; 2005 Aug 12-19; 384(1-2):23-8. PubMed ID: 15905028
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 23.